The aim of this call “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation” is to leverage the complementary expertise of scientists in different countries through collaborative, interdisciplinary research projects. Although Switzerland is not an associated country in Horizon Europe, Swiss-based applicants can join research consortia on equal terms with applicants from EU member states and other countries participating in the call. Further information can be found under the following link.